P

PW Medtech Group Ltd
HKEX:1358

Watchlist Manager
PW Medtech Group Ltd
HKEX:1358
Watchlist
Price: 1.29 HKD
Market Cap: 1.9B HKD

PW Medtech Group Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

PW Medtech Group Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
P
PW Medtech Group Ltd
HKEX:1358
Cash from Operating Activities
ÂĄ283.9m
CAGR 3-Years
28%
CAGR 5-Years
19%
CAGR 10-Years
6%
A
APT Medical Inc
SSE:688617
Cash from Operating Activities
ÂĄ743.4m
CAGR 3-Years
60%
CAGR 5-Years
68%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash from Operating Activities
ÂĄ1.9B
CAGR 3-Years
15%
CAGR 5-Years
-9%
CAGR 10-Years
16%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash from Operating Activities
ÂĄ8.6B
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Cash from Operating Activities
ÂĄ1.3B
CAGR 3-Years
-20%
CAGR 5-Years
-11%
CAGR 10-Years
13%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash from Operating Activities
-ÂĄ619m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

PW Medtech Group Ltd
Glance View

Market Cap
2B HKD
Industry
Health Care

PW Medtech Group Ltd. is an investment holding company, which engages in the manufacture and sale of infusion set products. The company is headquartered in Beijing, Beijing and currently employs 670 full-time employees. The company went IPO on 2013-11-08. The firm operates through three business segments. The Infusion Set Business segment is engaged in the manufacturing and sales of infusion sets. The Orthopedic Implant Business segment is engaged in the manufacturing and sales of orthopedic implant products, including product category of trauma, spine and joints. The Regenerative Medical Biomaterial Business segment is engaged in the manufacturing and sales of regenerative medical biomaterial products.

Intrinsic Value
2.39 HKD
Undervaluation 46%
Intrinsic Value
Price
P

See Also

What is PW Medtech Group Ltd's Cash from Operating Activities?
Cash from Operating Activities
283.9m CNY

Based on the financial report for Jun 30, 2025, PW Medtech Group Ltd's Cash from Operating Activities amounts to 283.9m CNY.

What is PW Medtech Group Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
6%

Over the last year, the Cash from Operating Activities growth was 5%. The average annual Cash from Operating Activities growth rates for PW Medtech Group Ltd have been 28% over the past three years , 19% over the past five years , and 6% over the past ten years .

Back to Top